24.06.2012 - Teva Pharmaceutical Industries rose more than 11% on Sunday after a U.S. court upheld Teva's patents for multiple sclerosis drug Copaxone well into 2015. Israel-based Teva, the...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)